Author

Andrew F. Read

Primary ORCID profile (0000-0001-7604-7903 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Andrew F. ReadiD2 papers · Pennsylvania State University

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

Troy Day· 1 shared

Activity by Year

2015-2015 · peak 1/yr

1 paper

Recent·Most cited

MicrobiologybioRxivJun 3, 2015

When does high-dose antimicrobial chemotherapy prevent the evolution of resistance?

Troy Day, Andrew F. Read

This paper shows high-dose chemotherapy can either prevent or promote antimicrobial resistance depending on ecological and mutational dynamics, suggesting optimal doses are at the extremes of the therapeutic window.

DOI 10.1371/journal.pcbi.1004689

statistical modeldrug response / drug discovery

𝕏 PostBluesky